SCHEMBL16633153

SCHEMBL16633153

Cc1cc([N+](=O)[O-])cc(C)c1C(=O)CBr

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.51
ALDH1A1 P00352 5/20 0.47
GPR35 Q9HC97 1/20 0.47
TDP1 Q9NUW8 4/20 0.46
CYP3A4 P08684 2/20 0.46
TSHR P16473 2/20 0.44
HTT P42858 3/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MAPK1 P28482 1/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 2/20 0.38
CYP19A1 P11511 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8094473 0.79 ALDH1A1 (0.52) ALDH1A1GPR35TDP1CYP3A4TSHR
SCHEMBL13199182 0.77 CA1 (0.55) ALDH1A1GPR35TDP1CYP3A4TSHR
SCHEMBL16632905 0.77 ALDH1A1 (0.53) ALDH1A1GPR35TDP1CYP3A4TSHR
SCHEMBL1770114 0.77 GSK3B (0.48) GSK3BALDH1A1KMT2AMEN1LMNA
SCHEMBL8099774 0.76 ALDH1A1 (0.52) ALDH1A1GPR35TDP1CYP3A4TSHR
SCHEMBL14992457 0.75 CYP3A4 (0.50) GSK3BALDH1A1TDP1CYP3A4KMT2A
SCHEMBL31415407 0.75 GSK3B (0.56) GSK3BALDH1A1TDP1CYP3A4TSHR
SCHEMBL14892423 0.74 ALDH1A1 (0.50) ALDH1A1GPR35TDP1CYP3A4TSHR
SCHEMBL14993161 0.74 GSK3B (0.38) GSK3BALDH1A1TSHRHTTKMT2A
SCHEMBL13613681 0.73 GAA (0.42) ALDH1A1GPR35TDP1CYP3A4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670197-B2 Small molecule modifiers of the Hec1-Nek2 interaction in G2/M THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-06-06 US disclosed
US-20160318918-A1 SMALL MOLECULE MODIFIERS OF THE HEC1-NEK2 INTERACTION IN G2/M THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-11-03 US disclosed
US-9422275-B2 Small molecule modifiers of the HEC1-NEK2 interaction in G2/M THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-08-23 US disclosed
US-20150105391-A1 SMALL MOLECULE MODIFIERS OF THE HEC1-NEK2 INTERACTION IN G2/M THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318918-A1 SMALL MOLECULE MODIFIERS OF THE HEC1-NEK2 INTERACTION IN G2/M NR2E1, NEK4, NCOR2 GSK3B 2388/4885ALDH1A1 3515/4885GPR35 2682/4885
US-20150105391-A1 SMALL MOLECULE MODIFIERS OF THE HEC1-NEK2 INTERACTION IN G2/M NR2E1, NEK4, NCOR2 GSK3B 2388/4885ALDH1A1 3515/4885GPR35 2682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.